Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 204.01 AUD -2.63% Market Closed
Market Cap: 21.3B AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+34%
Revenue
Forecast
+33%
Operating Income
Forecast
+38%
Net Income
Forecast
+39%

Wall Street
Price Targets

PME Price Targets Summary
Pro Medicus Ltd

Wall Street analysts forecast PME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PME is 272.99 AUD with a low forecast of 166.65 AUD and a high forecast of 325.5 AUD.

PME Lowest Forecast
Wall Street Target
166.65 AUD
18% Downside
PME Average Forecast
Wall Street Target
272.99 AUD
34% Upside
PME Highest Forecast
Wall Street Target
325.5 AUD
60% Upside
Lowest
Price Target
166.65 AUD
18% Downside
Average
Price Target
272.99 AUD
34% Upside
Highest
Price Target
325.5 AUD
60% Upside
Pro Medicus Ltd Competitors:
Price Targets
e
5038
eWeLL Co Ltd
33% Upside
PHR
Phreesia Inc
39% Upside
S
SOPH
Sophia Genetics SA
147% Upside
OMCL
Omnicell Inc
74% Upside
e
5038
eWeLL Co Ltd
33% Upside
PHR
Phreesia Inc
39% Upside
S
SOPH
Sophia Genetics SA
147% Upside
OMCL
Omnicell Inc
74% Upside
NUTX
Nutex Health Inc
53% Downside
INSP
Inspire Medical Systems Inc
65% Upside
300253
Winning Health Technology Group Co Ltd
1% Downside
G
688246
Goodwill E-Health Info Co Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
Pro Medicus Ltd

For the last 8 years the compound annual growth rate for Pro Medicus Ltd's revenue is 25%. The projected CAGR for the next 3 years is 33%.

25%
Past Growth
33%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pro Medicus Ltd

For the last 8 years the compound annual growth rate for Pro Medicus Ltd's operating income is 37%. The projected CAGR for the next 3 years is 38%.

37%
Past Growth
38%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pro Medicus Ltd

For the last 8 years the compound annual growth rate for Pro Medicus Ltd's net income is 38%. The projected CAGR for the next 3 years is 39%.

38%
Past Growth
39%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
PME intrinsic value, competitors valuation, and company profile.
DCF Valuation
PME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PME stock valuation using valuation multiples.
Wall Street Estimates
PME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PME's stock price target?
Price Target
272.99 AUD

According to Wall Street analysts, the average 1-year price target for PME is 272.99 AUD with a low forecast of 166.65 AUD and a high forecast of 325.5 AUD.

What is Pro Medicus Ltd's Revenue forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Pro Medicus Ltd's revenue is 25%. The projected CAGR for the next 3 years is 33%.

What is Pro Medicus Ltd's Operating Income forecast?
Projected CAGR
38%

For the last 8 years the compound annual growth rate for Pro Medicus Ltd's operating income is 37%. The projected CAGR for the next 3 years is 38%.

What is Pro Medicus Ltd's Net Income forecast?
Projected CAGR
39%

For the last 8 years the compound annual growth rate for Pro Medicus Ltd's net income is 38%. The projected CAGR for the next 3 years is 39%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 246,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.